Dr. Agarwal's Eye Hospital Limited (BOM: 526783)
India
· Delayed Price · Currency is INR 4,082.75
+4.30 (0.11%)
At close: Sep 10, 2024
Dr. Agarwal's Eye Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 3,408 | 3,193 | 2,681 | 2,012 | 1,398 | 1,760 | Upgrade
|
| Other Revenue | - | - | - | - | 5.17 | 13.39 | Upgrade
|
| Revenue | 3,408 | 3,193 | 2,681 | 2,012 | 1,403 | 1,773 | Upgrade
|
| Revenue Growth (YoY) | 22.01% | 19.10% | 33.24% | 43.39% | -20.85% | 3.76% | Upgrade
|
| Cost of Revenue | 1,925 | 1,868 | 1,576 | 649.3 | 510.69 | 613.65 | Upgrade
|
| Gross Profit | 1,483 | 1,325 | 1,105 | 1,363 | 892.57 | 1,159 | Upgrade
|
| Selling, General & Admin | - | 127.7 | 106.3 | 71.2 | 49.82 | 72.54 | Upgrade
|
| Other Operating Expenses | 484.7 | 282.4 | 246.1 | 714.8 | 522.15 | 605.63 | Upgrade
|
| Operating Expenses | 791 | 678.3 | 556.5 | 989.9 | 774.38 | 890.53 | Upgrade
|
| Operating Income | 691.9 | 646.8 | 548.3 | 372.9 | 118.19 | 268.75 | Upgrade
|
| Interest Expense | -85.8 | -71 | -68 | -61.2 | -61.31 | -73.9 | Upgrade
|
| Interest & Investment Income | - | 19.5 | 7.8 | 5.4 | 1.32 | 4.64 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -1.1 | -0.1 | -0.08 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 50.1 | 12.3 | 4.3 | 3.9 | -0.59 | -3.07 | Upgrade
|
| EBT Excluding Unusual Items | 656.2 | 607.6 | 491.3 | 320.9 | 57.53 | 196.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -2.3 | 0.3 | 2.2 | -0.2 | -1.2 | Upgrade
|
| Other Unusual Items | - | 17.2 | 2.4 | - | - | 4.19 | Upgrade
|
| Pretax Income | 656.2 | 622.5 | 494 | 323.1 | 57.33 | 199.41 | Upgrade
|
| Income Tax Expense | 166.9 | 158.9 | 124.8 | 82.1 | 71.71 | 62.57 | Upgrade
|
| Net Income | 489.3 | 463.6 | 369.2 | 241 | -14.39 | 136.83 | Upgrade
|
| Net Income to Common | 489.3 | 463.6 | 369.2 | 241 | -14.39 | 136.83 | Upgrade
|
| Net Income Growth | 24.35% | 25.57% | 53.20% | - | - | 14.84% | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | -0.01% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 104.11 | 98.64 | 78.55 | 51.28 | -3.06 | 29.11 | Upgrade
|
| EPS (Diluted) | 104.11 | 98.64 | 78.55 | 51.28 | -3.06 | 29.11 | Upgrade
|
| EPS Growth | 24.35% | 25.57% | 53.19% | - | - | 14.83% | Upgrade
|
| Free Cash Flow | - | 184.6 | -7.2 | 99.5 | 226.91 | 214.8 | Upgrade
|
| Free Cash Flow Per Share | - | 39.28 | -1.53 | 21.17 | 48.28 | 45.70 | Upgrade
|
| Dividend Per Share | - | 5.000 | 3.000 | 3.000 | - | - | Upgrade
|
| Dividend Growth | - | 66.67% | 0% | - | - | - | Upgrade
|
| Gross Margin | 43.52% | 41.50% | 41.21% | 67.73% | 63.61% | 65.39% | Upgrade
|
| Operating Margin | 20.30% | 20.26% | 20.45% | 18.53% | 8.42% | 15.16% | Upgrade
|
| Profit Margin | 14.36% | 14.52% | 13.77% | 11.98% | -1.03% | 7.72% | Upgrade
|
| Free Cash Flow Margin | - | 5.78% | -0.27% | 4.95% | 16.17% | 12.12% | Upgrade
|
| EBITDA | 1,001 | 779.5 | 643.8 | 489 | 226.98 | 387.27 | Upgrade
|
| EBITDA Margin | 29.36% | 24.41% | 24.01% | 24.30% | 16.18% | 21.84% | Upgrade
|
| D&A For EBITDA | 308.75 | 132.7 | 95.5 | 116.1 | 108.79 | 118.52 | Upgrade
|
| EBIT | 691.9 | 646.8 | 548.3 | 372.9 | 118.19 | 268.75 | Upgrade
|
| EBIT Margin | 20.30% | 20.26% | 20.45% | 18.53% | 8.42% | 15.16% | Upgrade
|
| Effective Tax Rate | 25.43% | 25.53% | 25.26% | 25.41% | 125.09% | 31.38% | Upgrade
|
| Revenue as Reported | 3,458 | 3,243 | 2,697 | 2,025 | 1,406 | 1,786 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.